A recording of the Sept. 28, 2022, webinar to educate stakeholders on the Green Chemistry Challenge Awards’ nomination process is now available. This webinar, hosted by the U.S. Environmental Protection Agency (EPA), reviewed the history of the awards, eligibility requirements, and what is needed to submit a nomination. The webinar also reviewed the six award categories including a category to recognize technology that reduces or eliminates greenhouse gas emissions, in support of the Biden-Harris Administration’s efforts to combat the climate crisis.  

EPA is currently accepting nominations for the 2023 Green Chemistry Challenge Awards from companies or institutions that have developed a new green chemistry process or product that helps protect human health and the environment. Nominations are due to the agency by Dec. 9, 2022. 

An independent panel of technical experts convened by the American Chemical Society Green Chemistry Institute will formally judge the nominations and make recommendations to EPA for the 2023 winners. EPA anticipates giving awards to outstanding green chemistry technologies in six categories in the Fall of 2023. 

Learn more about the Green Chemistry Challenge Awards. 

View the Webinar

A good course proposal needs to be clear, strategic, and aligned with the academic policies. OSU uses Curriculum Inventory Management (CIM) software as an online platform for curricular proposal submission and review. This course demonstrates how to navigate CIM to successfully submit a course proposal and explains the curriculum review workflow in a nutshell. Part of the Fall 2022 FYI Friday series; Friday, Nov. 4, noon to 12:30 p.m. via Zoom. Registration closes at noon on Thursday.

  • Development of Methods for Analysis of Food/Packaging
  • College Park, MD
  • 40hrs/week
  • Potential Start: 1/4/23,  1yr appointment, with possible 1yr renewal
  • Open to recent/upcoming MS/PhD chemistry graduates (US citizen or US residency 36 of last 60 months)

The participant will receive training in and will focus on; the mass spectrometry of food contaminants, polymers, and packaging, in particular ambient ionization, non-targeted analysis, suspect screening, database development, materials categorization, and methods validation. Activities will include sample preparation, mass spectrometric method development and analysis, database creation/curation, open-source software adaption and/or workflow development, method comparison, method validation, and ion identification.  Experience performing analytical chemistry research and/or mass spectrometry research is required.  Experience in planning and executing statistically complex scientific studies, and/or utilizing ambient ionization, and/or high-resolution mass spectrometry is preferred.  Experience with KNIME, R, and/or Xcalibur/TraceFinder is a positive. The ability to effectively communicate both verbally and in writing is essential.

Please contact Luke Ackerman, Luke.Ackerman@fda.hhs.gov, for more information.

During the EAS symposium, please contact Susie Genualdi, susan.genualdi@fda.hhs.gov, or 989-430-3730 to discuss this opportunity further. 

  • Development of Methods for Halogen Analysis of Food/Packaging
  • College Park, MD
  • 40hrs/week
  • Potential Start: 1/4/23,  1yr appointment, with possible 1yr renewal
  • Open to recent/upcoming BS/MS chemistry graduates (US citizen or US residency 36 of last 60 months)

The project will stand-up and investigate combustion ion chromatography methods for total fluorine analyses of packaging and food. The ORISE participant will receive training in and will focus on: chemical analysis methods for halogen and per/polyfluoro substances, method development and validation. Activities will include instrument set-up, troubleshooting, sample preparation, halogen method development and analysis, method comparison, and method validation.  Experience performing chemical analysis with combustion, halogenated analytes, and/or ion-chromatography analysis is required. Experience in instrumental set-up, troubleshooting, and/or method development is preferred.  Experience with total fluorine or PFAS analysis is a positive. The ability to effectively communicate both verbally and in writing is essential. 

Please Contact Luke Ackerman, Luke.Ackerman@fda.hhs.gov, for more information.

If attending the EAS’22 symposium, please contact Susie Genualdi, susan.genualdi@fda.hhs.gov, or 989-430-3730 to discuss this opportunity further. 

Dr. Nir Modiano (modiano@ohsu.edu) from OHSU, is looking to collaborate with a chemist or toxicologist on an effort to understand whether the therapeutic PPS may contribute to inflammatory bowel disease.

“Briefly, PPS is a sulfated polysaccharide that is used as a therapy for interstitial cystitis.  We have found that a few of our IBD patients on PPS improved after stopping the PPS.  In the 1990’s studies of high-dose PPS use for bladder cancer were dose-limited by proctitis, supporting the notion that it could be a causative agent in colitis.  We then noticed a number of patients on it developed multifocal dysplasia, requiring colectomy to prevent progression to malignancy.  Since the number of patients taking PPS is fairly small, we collaborated with Stanford and identified 30 patients with IBD who had been on PPS for >2 years (arbitrarily chosen because we did not want to include patients who had minimal exposure).  Of these, 1 in 3 developed multifocal dysplasia as of time of our study, which is a very high number.  We think this case series supports the hypothesis that PPS may increase the risk of both IBD and colonic dysplasia, though obviously, a small case series is not a definitive study.     

Of note, PPS may share similiarities in chemical structure with DSS, and both are sulfated polysaccharides, though we have not yet had a chemist or toxicologist weigh in on whether the similarities are likely to be relevant.  We’d be interested in gaining perspective from someone with relevant experience in toxicology to help us understand our observations and, perhaps, collaborate on research related to these findings.  One reason I find this so interesting is that it may offer insight into other environmental exposures that may be contributing to the rapid increase in IBD cases we are seeing in the western world, and perhaps, the increased rates of colorectal cancer at younger ages.”

Dear Oregon State Colleagues,

We are pleased to announce the launch of the Research Impact and Advancement Academy on Friday, October 21. This Academy is designed by the new Office for Research Advancement to bolster and enhance the ability for OSU researchers to successfully lead and compete for large collaborative proposals. It will provide a social learning structure where faculty can develop the knowledge, skills, practices, and relationships to successfully lead large transdisciplinary proposals, and execute and manage funded solutions-focused research programs.

In the inaugural year of the Academy, 20 Fellows have been selected in close cooperation with the Deans and Associate Deans for Research. They represent expertise across colleges and a wide range of the research strengths at OSU. The Fellows will enter the Academy for a two-year program starting out with a series of ten workshops for the first year. In these workshops, they will develop mindsets and frameworks for leading large transdisciplinary research efforts and will be provided the tools and practices of leading this type of work. During the Spring term, the Fellows will develop a multi-year plan and proposal for success and pitch for seed funds to pursue those plans. The Academy will be recurring with a new cohort of faculty every academic year.

Integrated into this first Academy cohort will be ten Valley Fellows concentrating on solutions to significant biohealth challenges. The biohealth sciences focuses on human health in a holistic manner, by identifying mechanisms and health risks, with emphasis on optimizing health through both prevention and treatment. Proposal development will be aiming for NIH and other funding opportunities focused on biohealth sciences. The Valley Fellows Program is funded through a generous grant from the Wayne and Gladys Valley Foundation.

Finally, the Office of Research Advancement is rolling out additional workshops and organizing several campus conversations. In total, seven Research Office Campus Conversations (ROCC) and two to three Research Office Lunch and Learn (ROLL) workshop series will be organized each academic year. Topics include ‘Demystifying USDA Funding’, ‘Going for Large Center/Facility Proposals’, ‘Integrating JEDI into Proposal Writing’ and ‘New-to-NIH’. In addition, the Research Office Advancement IGNITE series will bring university-wide communities together around broad research themes that are eminently growing in importance and strength at OSU. Topics this coming year include ‘Public Health and Climate Change’, ‘Water Resilience’ and ‘Renewable Clean Energy’.

Our offices are committed to supporting your success in accomplishing our research mission. Together, all of these new activities are in support of further advancing the research enterprise and scholarship at OSU while increasing the impact of our work in the arenas of both transdisciplinary research and scholarship and use-inspired research, two areas where OSU is extremely well positioned to excel and become leaders.

Sincerely,

Edward Feser

Provost and Executive Vice President

Irem Tumer

Vice President for Research